MENA 2024 Recordings-Molecular Testing in Thyroid Nodules and Cancer

Molecular Testing in Thyroid Nodules and Cancer - Dr. Ali Alzahrani -
Video Transcription
Well, thank you so much for the privilege of talking to you today about the Molecule experiments in Teroid, Nodiol, and Egypt. I have nothing to tell you except that I asked you to give this topic a try.  This is my third topic in three or three months, so I apologize to those who saw the topic before and there is no way to stop the experiments in some provinces  But I think different counties are different, and I hope you learn something. This is my talking lines, and I'm going to talk a little bit about the nodule teroid as an interview, and I'm going to talk about the main electrical change in the cancer teroid.  And use this information for training, exercises and enrichments.  You may have seen this county several times that Nudiol Teroid as an interview is very Dr. Alexander finally points this out well in many counties and there is really Nudiol Teroid as an interview  You can see that by the age of 65 to 70, about 50% of the population will be neurodegenerative. This is a very big impact on the ecosystem, on us as a trader, and on the patients.  These are the exercises that you use today extensively and many times using them without even pointing out that the patient of course has become less than the patient  But still, thyrotoxicosis occurs in only about 5 to 10% of the population through training so we all know that when we see a patient with thyrotoxicosis,  After activating the commercial investigation, the courtyard is basically the primary to check these patients and the courtyard answers about 80% to 85% of the case on the right side, teroid nodule occurs in about 65%  Teroid nodule occurs in about 5 to 10% but we are left with this basic group, which today we call Patizda 3 and 4.  This means that the hospital cannot give you a definitive answer as to whether a patient with thyrotoxicosis is a patient or not, so the basic training up until about a year and a half ago was to send these patients to the hospital.  Because the pathological damage in these patients is not significant, it is about 20% to 40%, so you cannot get rid of this desire and send the patients to basic training, usually for Bactim or sometimes for Thyroid Nodiol.  But it turns out that 70% of the time the last basic training is not content so the training is not content if we knew ahead of time that this was going to be not content we would not send these patients to training  Only 30% will have any ambient training.  The question that has been asked for about 15 years or more is can we use ambient training to get rid of these nodules so we can reduce the training content and more recently, we started asking another question.  Can we use the peripheral data to decide what type of peripheral training we do this because of the peripheral files so when we find something like peripheral training the third peripheral  We have to do the third environment training and when we find the third environment training we have to do the third environment training these are the questions that are being achieved and I will talk about them more  The Bethsader system  And it was given for use, on the night side you can see GSC the United Trade Organization for Holocolate Sequencing so, at the holocolate sequencing level 24% they tried 191 nodules.  Holocal sequence 91% False holo sequence 96% These two are the important fundamentals of controlling the holo sequence So, False holo sequence and Open open value  It makes the holo sequence very good for controlling the holo sequence so this is the wrong holo sequence you can see the open value open and the open value less  So, the holo sequence controls the training and makes the training not open like controlling the elimination of angels. Same thing for Terosic Versen 3. On the 28th they tested 257 Nodols.  Its effect is 94%. Its de-angel value is 97%. So again, it's an excellent de-angel experience. It has the best privacy and proper de-angel value but it's not that different from Afra GSC.  So it's not a throw away experience. Terogen, then Terramir. Again, throw away experience 30%. They tried 178 Nodols. Although the model here looks better.  But again, it has not been tried perfectly. To try to get rid of the right angels perfectly requires a different definition. It requires decisions to get rid of the right angels.  This was not the case in Terogen. In Terogen, it was a perfectly good angel-removal experience. In the others, it was a perfectly good angel-removal experience.  Experience the perfect get rid of the angels.  Not only the important identification experience but also the real experience. This is also an important thing called the experience of getting rid of the right angels. The experience of getting rid of the right angels means what is the group of patients  Which experience gets rid of the perfect fit angels?  Yes, an excellent angel elimination experience.  If we look at the left side, in the general group, the participation is almost like, more than the average damage but if we look at the general average group,  We can see 21% of the general average group, 15% of the average group, and 3% of the average damage. If we look at any of the ideas here on this page, like the average damage,  Such as, for example, moderate damage.